Perhaps look at the details more carefully on the 'Trump idea' and how it impacts (or doesn't) BOT. Then those proposed cuts even if he tries to implement will likely be in the courts for well over a year or longer due to the legal clout of the whole pharmaceutical industry. You may agree with the cuts - but you would be in the vast minority - including the legal system there imo.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)